Efficacy and Safety of Canakinumab in Patients with TNF Receptor Associated Periodic Syndrome

被引：0
|
作者：
Gattorno, Marco [1 ]
Obici, Laura [2 ]
Meini, Antonella
Tormey, Vincent [3 ]
Abrams, Ken [4 ]
Davis, Nicole [4 ]
Andrews, Christopher [5 ]
Lachmann, Helen J. [6 ]
机构：
[1] Ist Giannina Gaslini, I-16148 Genoa, Italy
[2] IRCCS Policlin San Matteo, Pavia, Italy
[3] Galway Univ Hosp, Galway, Ireland
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] Novartis Pharmaceut UK Ltd, Surrey, England
[6] UCL, Sch Med, London W1N 8AA, England
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
749
引用
收藏
页码：S322 / S322
页数：1
相关论文
共 50 条
  • [31] Guidance on the use of canakinumab in patients with cryopyrin-associated periodic syndrome in Japan
    Yokota, Shumpei
    Nishikomori, Ryuta
    Takada, Hidetoshi
    Kikuchi, Masako
    Nozawa, Tomo
    Kanetaka, Taichi
    Kizawa, Toshitaka
    Miyamae, Takako
    Mori, Masaaki
    Heike, Toshio
    Hara, Toshiro
    Imagawa, Tomoyuki
    MODERN RHEUMATOLOGY, 2013, 23 (03) : 425 - 429
  • [32] Successful Treatment of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome With Canakinumab
    Brizi, Maria Giuseppina
    Galeazzi, Mauro
    Lucherini, Orso Maria
    Cantarini, Luca
    Cimaz, Rolando
    ANNALS OF INTERNAL MEDICINE, 2012, 156 (12) : 907 - 908
  • [33] Efficacy and safety of Canakinumab (ILARIS®) in Cryopyrin-Associated Periodic Syndrome (CAPS): Interim results of an onging phase III study
    Leslie, K. S.
    Kuemmerle-Deschner, J. B.
    Lachmann, H. J.
    Hachulla, E.
    Hoyer, J.
    Smith, J.
    Kone-Paut, I.
    Braun, I.
    Widmer, A.
    Patel, N.
    Preiss, R.
    Hawkins, P. N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S9 - S9
  • [34] Canakinumab for treatment of cryopyrin-associated periodic syndrome
    Feist, Eugen
    Burmester, Gerd R.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (11) : 1631 - 1636
  • [35] Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort
    Anton, J.
    Calvo, I.
    Fernandez-Martin, J.
    Gamir, M. L.
    Merino, R.
    Jimenez-Trevino, S.
    Sevilla, B.
    Cabades, F.
    Bou, R.
    Arostegui, J. I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (06) : S67 - S71
  • [36] Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
    Lachmann, Helen J.
    Kone-Paut, Isabelle
    Kuemmerle-Deschner, Jasmin B.
    Leslie, Kieron S.
    Hachulla, Eric
    Quartier, Pierre
    Gitton, Xavier
    Widmer, Albert
    Patel, Neha
    Hawkins, Philip N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (23) : 2416 - 2425
  • [37] Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)
    Francesco La Torre
    Maurizio Muratore
    Antonio Vitale
    Fulvio Moramarco
    Laura Quarta
    Luca Cantarini
    Rheumatology International, 2015, 35 : 1943 - 1947
  • [38] Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)
    La Torre, Francesco
    Muratore, Maurizio
    Vitale, Antonio
    Moramarco, Fulvio
    Quarta, Laura
    Cantarini, Luca
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (11) : 1943 - 1947
  • [39] Safety of Canakinumab in a Large Cohort of Patients with Cryopyrin-Associated Periodic Syndrome: Results From the β-Confident Registry.
    Hoffman, H.
    Kuemmerle-Deschner, J. B.
    Hawkins, P.
    van der Poll, T.
    Walker, Ulrich A.
    Rauer, B.
    Nebesky, J. M.
    Tilson, H.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S78 - S78
  • [40] EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH NOMID/CINCA
    Goldbach-Mansky, R.
    Sibley, C.
    Felix, S. D.
    Brewer, C.
    King, K.
    Zalewski, C.
    Kim, H. J.
    Bishop, R.
    Chakraborty, A.
    Colin, L.
    Chioato, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 291 - 291
12345